相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CpG-Islands as Markers for Liquid Biopsies of Cancer Patients
Maximilian Sprang et al.
CELLS (2020)
Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma
Liping Zhuang et al.
CANCER CONTROL (2020)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target
Chin-Sheng Hung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma
Shenghua Hao et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B
Ming-Ming Tian et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression
Yang Chen et al.
SCIENTIFIC REPORTS (2017)
Methylation of SOX1 and VIM promoters in serum as potential biomarkers for hepatocellular carcinoma
X. Y. Liu et al.
NEOPLASMA (2017)
Up-regulation of A20 gene expression in peripheral blood mononuclear cells is associated with acute-on-chronic hepatitis B liver failure
Y. -C. Fan et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer
A. Amatu et al.
ANNALS OF ONCOLOGY (2016)
Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma
Sheng-xian Yuan et al.
CANCER LETTERS (2016)
The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features
Lu Wang et al.
PLOS ONE (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate
Silvia Udali et al.
HEPATOLOGY (2015)
Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry
Hui-Chen Wu et al.
CARCINOGENESIS (2012)
Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma
Yongfeng Wang et al.
LIVER INTERNATIONAL (2012)
DNA methylation in white blood cells Association with risk factors in epidemiologic studies
Mary Beth Terry et al.
EPIGENETICS (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Surgical Treatment for Hepatocellular Carcinoma
Tadatoshi Takayama
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Methylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinoma
Masahito Tsutsui et al.
CLINICA CHIMICA ACTA (2010)
Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma
Toyoki Moribe et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Promoter Methylation in APC, RUNX3, and GSTP1 and Mortality in Prostate Cancer Patients
Lorenzo Richiardi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Hepatocellular carcinoma in the Asia pacific region
Man-Fung Yuen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients
Qinghua Feng et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver
Jan Harder et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma
Ray-Hwang Yuan et al.
CLINICAL CANCER RESEARCH (2007)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: A case control study
M Pufulete et al.
GASTROENTEROLOGY (2003)
Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
H Imamura et al.
JOURNAL OF HEPATOLOGY (2003)
分享论文
